Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema
ICD-10 E09.351 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema.
E09.351 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of proliferative diabetic retinopathy and macular edema. This condition arises when certain medications, such as glucocorticoids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. Proliferative diabetic retinopathy is a severe complication of diabetes, where abnormal blood vessels grow in the retina, potentially leading to vision loss. Macular edema, a common consequence of diabetic retinopathy, occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. Management of this condition often requires a multidisciplinary approach, including endocrinologists for diabetes management and ophthalmologists for eye care. Regular monitoring of HbA1c levels is crucial to assess long-term glucose control, with targets typically set below 7% for most adults. Insulin therapy may be necessary for glycemic control, especially in cases where oral medications are ineffective due to the severity of the condition.
Detailed medication history, HbA1c levels, and treatment plans.
Patients presenting with uncontrolled blood sugar levels due to medication.
Ensure clear documentation of the drug responsible for diabetes and its management.
Visual acuity tests, retinal examination findings, and treatment plans for retinopathy.
Patients with diabetes presenting with vision changes or retinal findings.
Document the extent of retinopathy and any interventions performed.
Used for routine eye exams in diabetic patients.
Document visual acuity, retinal findings, and any interventions.
Ophthalmologists should ensure thorough documentation of diabetic complications.
Common drugs that can induce diabetes include glucocorticoids, certain antipsychotics, and some antiretroviral medications. These drugs can lead to insulin resistance or impaired insulin secretion.
Proliferative diabetic retinopathy is diagnosed through a comprehensive eye examination, which may include retinal imaging and visual acuity tests to assess the extent of the disease.
The target HbA1c level for most adults is typically below 7%, but individual goals may vary based on patient-specific factors.
Macular edema is a serious complication of diabetic retinopathy that can lead to vision loss. It occurs due to fluid accumulation in the macula, affecting central vision.
